Intensive blood pressure-lowering treatment reduces the risk of recurrent stroke by 38 percent in adults who have survived an intracerebral hemorrhage, according to a meta-analysis published in The Lancet Neurology. The findings show that targeting defined blood pressure goals prevents recurrent strokes without increasing serious adverse events.
Evaluating Treatment Strategies After Intracerebral Hemorrhage
People who survive an intracerebral hemorrhage (ICH) — a type of haemorrhagic stroke — face a heightened risk of subsequent strokes. Two of the evaluated studies investigated fixed-dose antihypertensive therapies, while the remaining two tested treatment strategies based on defined blood pressure targets.
During a follow-up period lasting up to six years, researchers tracked how many patients suffered subsequent strokes. Recurrent stroke of any type occurred in 6.5 percent of patients who received intensive blood pressure-lowering therapy, compared to 10.4 percent of those in the control arm who received less intensive treatment or standard care according to the study results. That difference translates to a 38 percent reduction in the overall risk of recurrent stroke, driven largely by an approximate 61 percent drop in recurrent ICH among patients receiving intensive treatment.
Safety Profiles and Blood Pressure Thresholds
Medical professionals frequently balance the goal of reducing vascular pressure against the risk of adverse side effects. In this meta-analysis, the average systolic blood pressure during follow-up reached 127 mmHg in the intensive treatment group compared to 138 mmHg in the control group, establishing a mean difference of 11.2 mmHg. Crucially, researchers detected no significant increase in serious adverse events between the two approaches. Serious events occurred in approximately 29 percent of patients in the intensive treatment arm, compared to 33 percent of patients receiving standard care.
“Generally, guidelines recommend treatment to a target of less than 130/80mmHg, but our study showed that patients at or below this threshold can still face a significant risk of recurrent stroke.”
Craig Anderson, senior author and senior professorial fellow at The George Institute for Global Health
Subgroup analyses confirmed that the advantages of intensive blood pressure management remained consistent regardless of the time elapsed since the initial hemorrhage or the patient’s baseline blood pressure levels. Even individuals whose baseline blood pressure met conventional guidelines derived significant protection from further aggressive lowering.
Clinical Implications for Secondary Prevention
Hemorrhagic strokes represent roughly 15 percent of all strokes, with intracerebral hemorrhage forming around two-thirds of hemorrhagic cases. Because ICH is one of the deadliest forms of stroke with limited treatment options, secondary prevention remains vital as noted by study author Craig Anderson.
“Our analysis shows that intensive blood pressure treatment can prevent 16 recurrent strokes for every 1,000 patients treated within the first year alone. These findings reinforce the central role of blood pressure control in secondary stroke prevention.”
Craig Anderson, senior author and senior professorial fellow at The George Institute for Global Health
External specialists reviewing the data emphasized the practical challenges of translating these targets into everyday clinical practice.
